Delivery Order SPE2DB20D1100-SPE2DB25FE0SD
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,318.60 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100 count units). The contract is a firm fixed price, non-set-aside delivery order with an ultimate completion date of July 31, 2025, awarded on July 30, 2025. AmerisourceBergen Drug Corp will perform this work from its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 24, 2025, for the supply of Methylphenidate ER (extended-release) tablets at 54mg dosage. This firm fixed-price delivery order, valued at $6,673.17, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, which carries a $999,999,999.00 ceiling value through December 2026. The...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,067.06 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles). The contract employs firm fixed-price terms with an ultimate completion date of June 18, 2025, and was awarded on June 17, 2025, without set-aside designation. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), a...
- The Defense Logistics Agency awarded a delivery order valued at $2,062.28 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) on August 4, 2025, with completion scheduled for August 5, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and is performed at the contractor's facility in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count units) with a ceiling value of $2,478.27. This is a competitively awarded, firm fixed-price delivery order with no set-aside designation and an ultimate completion date of September 4, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and fulfills the order from its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count) under a firm fixed-price arrangement with a ceiling value of $1,297.75. This non-set-aside contract will be performed at the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of September 3, 2025. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,649.02 to AmerisourceBergen Drug Corp for Methylphenidate ER 54 mg tablets (100-count units) on July 24, 2025, with completion targeted for July 25, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,630.67 to AmerisourceBergen Drug Corp for Methylphenidate ER 27 mg tablets (100-count containers) with an ultimate completion date of September 15, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to the company's...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on September 16, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count bottles) with a ceiling value of $1,440.74. This competitive, non-set-aside award is structured as a firm fixed-price delivery order and is scheduled for completion by September 17, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,382.19 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 36 mg tablets (100-count bottles) with an ultimate completion date of September 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's broader pharmaceutical supply framework with the federal government. The product will be delivered to the company's facility...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0SDDelivery Order
The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $5,056.81 for Methylphenidate ER 54 mg tablets (100-count units) on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price contract was competitively awarded without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement extending through December 2026 that serves as a comprehensive global pharmaceutical support vehicle. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, maintains an extensive portfolio of federal medical supply contracts primarily with the DLA Medical Supply Chain. The company supplies a broad spectrum of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs, the Defense Health Agency, and other federal healthcare systems. This delivery order for methylphenidate, a Schedule II controlled substance commonly used for attention deficit hyperactivity disorder treatment, exemplifies the company's critical role in fulfilling federal pharmaceutical procurement requirements across diverse medical specialties.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 9/22/25 |